Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On July 31, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- Krognes converted 154 restricted stock units into 154 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Krognes directly owns 9,448 shares of common stock and 3,549 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| August 9, 2022 | Date of grant for the restricted stock unit award. |
| June 30, 2023 | First vesting date for 25% of the restricted stock units. |
| July 31, 2024 | Date of the reported transaction where restricted stock units were converted to common stock. |
| August 1, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.